Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sylvain Baize

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
Journal of Virology|March 30, 2018
A Vaccine Platform against Arenaviruses Based on a Recombinant Hyperattenuated Mopeia Virus Expressing Heterologous GlycoproteinsXavier Carnec, Mathieu Mateo, Audrey Page, et al.
Plos Pathogens|April 17, 2025
Expansion of myeloid suppressor cells and suppression of Lassa virus-specific T cells during fatal Lassa feverBlaise Lafoux, Gustave Fourcaud, Jimmy Hortion, et al.
Plos Pathogens|December 9, 2024
Fatal Lassa fever in cynomolgus monkeys is associated with systemic viral dissemination and inflammationJimmy Hortion, Emeline Perthame, Blaise Lafoux, et al.
CPT: Pharmacometrics & Systems Pharmacology|March 22, 2020
Modeling Favipiravir Antiviral Efficacy Against Emerging Viruses: From Animal Studies to Clinical TrialsVincent Madelain, France Mentré, Sylvain Baize, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 23, 2017
Dynamics of Ebola RNA Persistence in Semen: A Report From the Postebogui Cohort in GuineaFabien Subtil, Charlotte Delaunay, Alpha Kabinet Keita, et al.
International Journal of Molecular Sciences|October 14, 2023
Novel Antiviral Molecules against Ebola Virus InfectionMila Collados Rodríguez, Patrick Maillard, Alexandra Journeaux, et al.
Lancet (London, England)|March 19, 2023
Immunogenicity, safety, and tolerability of a recombinant measles-vectored Lassa fever vaccine: a randomised, placebo-controlled, first-in-human trialRoland Tschismarov, Pierre Van Damme, Clara Germain, et al.
The Lancet. Infectious Diseases|January 18, 2017
Multidisciplinary assessment of post-Ebola sequelae in Guinea (Postebogui): an observational cohort studyJean-François Etard, Mamadou Saliou Sow, Sandrine Leroy, et al.
Emerging Infectious Diseases|August 24, 2019
Fatal Case of Lassa Fever, Bangolo District, Côte d'Ivoire, 2015Mathieu Mateo, Caroline Picard, Yahaya Sylla, et al.
Open Forum Infectious Diseases|March 5, 2020
A 40-Month Follow-Up of Ebola Virus Disease Survivors in Guinea (PostEbogui) Reveals Long-Term Detection of Ebola Viral Ribonucleic Acid in Semen and Breast MilkAlpha Kabinet Keita, Nicole Vidal, Abdoulaye Toure, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Journal of Virology|March 30, 2018
A Vaccine Platform against Arenaviruses Based on a Recombinant Hyperattenuated Mopeia Virus Expressing Heterologous GlycoproteinsXavier Carnec, Mathieu Mateo, Audrey Page, et al.
Plos Pathogens|April 17, 2025
Expansion of myeloid suppressor cells and suppression of Lassa virus-specific T cells during fatal Lassa feverBlaise Lafoux, Gustave Fourcaud, Jimmy Hortion, et al.
Plos Pathogens|December 9, 2024
Fatal Lassa fever in cynomolgus monkeys is associated with systemic viral dissemination and inflammationJimmy Hortion, Emeline Perthame, Blaise Lafoux, et al.
CPT: Pharmacometrics & Systems Pharmacology|March 22, 2020
Modeling Favipiravir Antiviral Efficacy Against Emerging Viruses: From Animal Studies to Clinical TrialsVincent Madelain, France Mentré, Sylvain Baize, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 23, 2017
Dynamics of Ebola RNA Persistence in Semen: A Report From the Postebogui Cohort in GuineaFabien Subtil, Charlotte Delaunay, Alpha Kabinet Keita, et al.
International Journal of Molecular Sciences|October 14, 2023
Novel Antiviral Molecules against Ebola Virus InfectionMila Collados Rodríguez, Patrick Maillard, Alexandra Journeaux, et al.
Lancet (London, England)|March 19, 2023
Immunogenicity, safety, and tolerability of a recombinant measles-vectored Lassa fever vaccine: a randomised, placebo-controlled, first-in-human trialRoland Tschismarov, Pierre Van Damme, Clara Germain, et al.
The Lancet. Infectious Diseases|January 18, 2017
Multidisciplinary assessment of post-Ebola sequelae in Guinea (Postebogui): an observational cohort studyJean-François Etard, Mamadou Saliou Sow, Sandrine Leroy, et al.
Emerging Infectious Diseases|August 24, 2019
Fatal Case of Lassa Fever, Bangolo District, Côte d'Ivoire, 2015Mathieu Mateo, Caroline Picard, Yahaya Sylla, et al.
Open Forum Infectious Diseases|March 5, 2020
A 40-Month Follow-Up of Ebola Virus Disease Survivors in Guinea (PostEbogui) Reveals Long-Term Detection of Ebola Viral Ribonucleic Acid in Semen and Breast MilkAlpha Kabinet Keita, Nicole Vidal, Abdoulaye Toure, et al.
Pageof 7